Join us on Oct 21 for a virtual event – How to Start & Scale a Biotech Company Register Now
RNA Therapeutics R&D Solution

Realize the Potential of RNA Therapeutics

Design, develop, and characterize novel RNA therapeutics on a unified digital platform.

A New Approach to Software for Emerging RNA Therapeutics

RNA therapeutics have the potential to reach biological targets in ways that small molecules and antibodies cannot, and companies focused on these applications are on the verge of treating previously ‘undruggable’ diseases. Breakthroughs have come by focused research on RNA biology, as well as the chemical modifications of underlying oligonucleotides to improve biophysical properties.

R&D teams working on RNA therapeutics require digital solutions that can design, develop, and experiment with molecules that leverage both biological and chemical properties. Yet this combination is not readily found in legacy software that was built only around small molecule or antibody workflows. A new approach is required to bring a common data foundation to RNA therapeutic development, and to provide full traceability across sequences, chemical modifications, experiments, and process development.

Join the hundreds of companies already using Benchling

  • MiNA Therapeutics
  • Ribometrix
  • Strand Therapeutics
  • R&D Capabilities
  • Benefits

RNA Therapeutics R&D Solution

  • Design oligos with Benchling
    Design oligos
    • Visualize and modify sequences with an intuitive user interface
    • Standardize oligo sequence design with HELM and IDT syntax
    • Automate creation and modification of oligo sequences with REST APIs
  • Characterize oligos using Benchling
    Characterize oligos
    • Standardize experimental data capture with results table
    • Centralize all sample-relevant results automatically
    • Visualize analytical results with custom dashboards
  • Share oligos and results for RNA therapeutics R&D
    Share oligos and results
    • Leverage institutional knowledge across teams with a custom monomer library
    • Find both natural and chemically modified sequences with search features
    • Share HELM and IDT notations of oligo sequences with vendors and collaborators
Design oligos with Benchling
Key Features
  • Visualize and modify sequences with an intuitive user interface
  • Standardize oligo sequence design with HELM and IDT syntax
  • Automate creation and modification of oligo sequences with REST APIs
Characterize oligos using Benchling
Key Features
  • Standardize experimental data capture with results table
  • Centralize all sample-relevant results automatically
  • Visualize analytical results with custom dashboards
Share oligos and results for RNA therapeutics R&D
Key Features
  • Leverage institutional knowledge across teams with a custom monomer library
  • Find both natural and chemically modified sequences with search features
  • Share HELM and IDT notations of oligo sequences with vendors and collaborators

RNA Therapeutics R&D Solution

Benchling’s RNA Therapeutics Solution was developed in partnership with leading industry innovators. For the first time, R&D teams can design chemically modified oligonucleotides, centralize experimental results, standardize on syntax, and collaborate with teammates more effectively on a single platform. This modern digital R&D solution combines the capabilities expected from in silico design tools, ELN, and LIMS into one modern, unified, fully-configurable, and easy-to-use solution that adapts to the rapidly evolving needs of RNA therapeutics R&D.

ACCELERATE YOUR R&D
  • Simplify collaboration across multidisciplinary teams
    Scientists design oligos with intuitive design tools, centralize experimental data, standardize sequence design, and establish a scalable common language across organizations.
  • Improve data quality and real-time scientific insights
    Scientists keep consistent records across experiments, automatically centralize all key results, and aggregate results from diverse assays for real-time visualization in-platform.
  • Accelerate the speed of the entire RNA therapeutic lifecycle
    Scientists and executives quickly track oligo modifications and consequent impact on biological activity to rapidly iterate on oligo candidates with customizable decision support tools.
“At Ribometrix we use specialized technology to identify therapeutically compelling RNAs. As a platform therapeutics company, we create differently modified RNAs for the assays we run. With Benchling, we have manageable uniqueness verification processes that gives our scientists access to the same data.”
Katie Warner

VP, RNA Biology

How We Deliver

  • Dedicated Expertise
    Our Customer Experience professionals possess deep scientific expertise, as well as training on information technology best practices. They apply this know-how to support RNA therapeutic customers across a wide range of R&D teams.
  • Continuous Oversight
    Leverage Benchling's pre-implementation solutions consulting, professional implementation services, and customer success management expertise to help you get the most out of Benchling.
  • Focused R&D Support
    Take advantage of Benchling’s foundational implementation guides, developed by our Customer Experience team to support many RNA Therapeutic R&D functions.

Request a Demo Now

See why more than 200,000 scientists trust Benchling to power their R&D
Request Demo_Industry Solutions